INVO Fertility Amends Loan Agreement with Decathlon Alpha, Increases Monthly Payments and Secures Lender Waivers

Reuters
Sep 27
INVO Fertility Amends Loan Agreement with Decathlon Alpha, Increases Monthly Payments and Secures Lender Waivers

**INVO Fertility Inc. Amends Loan Agreement, Increases Repayment Obligations** INVO Fertility Inc. announced that on August 13, 2025, it entered into a third amendment to its existing loan agreement with Decathlon Alpha V LP and other parties. Under the new terms, the lender consented to the company's name change to INVO Fertility, Inc., and waived a potential event of default related to a separate legal judgment. The amendment also includes an adjusted repayment schedule, increasing INVO Fertility's monthly loan payments by $20,000. Additionally, the company agreed to reimburse the lender approximately $17,500 in fees and expenses related to the amendment. Further details are available in the company's latest Form 10-Q filing with the SEC.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-015821), on September 26, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10